3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroblastoma
8
Ganglioneuroblastoma
4
Triple Negative Breast Neoplasms
3
Melanoma
3
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
2
Adenoma, Islet Cell
2
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Resectable Esophageal Cancer
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Locally Advanced Pancreatic Adenocarcinoma
1
Leukemia, Plasma Cell
1
Gliosarcoma
1
Glioblastoma
1
Endometrial Neoplasms
1
Carcinosarcoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Merkel Cell
1
Carcinoma, Intraductal, Noninfiltrating
1
Carcinoma, Hepatocellular
1
Interventions
Cyclophosphamide
15
fludarabine phosphate
11
fludarabine
11
Whole-Body Irradiation
11
Mycophenolic Acid
11
Busulfan
9
Melphalan
8
Tacrolimus
7
Peripheral Blood Stem Cell Transplantation
7
Granulocyte Colony-Stimulating Factor
5
Cyclosporine
5
Azacitidine
5
Filgrastim
4
venetoclax
3
Cord Blood Stem Cell Transplantation
3
Biopsy
3
thymoglobulin
2
decitabine and cedazuridine drug combination
2
Vorinostat
2
Thiotepa
2
Specimen Handling
2
Sirolimus
2
Rituximab
2
Methotrexate
2
Injections
2
Hematopoietic Stem Cell Transplantation
2
Etoposide
2
Cytarabine
2
Cyclosporins
2
Clofarabine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anemia, Refractory, with Excess of Blasts
×
Colony-Stimulating Factors
×
1 year
×
Clear all
No trials found.